This Week in Psychedelics - 2.11.22

Cannabis

• South Carolina Medical Marijuana Legalization Bill Officially Approved In Senate, Heads For House Consideration (Marijuana Moment)

• Maryland Lawmakers Introduce Adult-Use Cannabis Legalization Bill (High Times)

• UK trial of medical cannabis and long covid to get underway this month (Cannabis Health News)

• The Super Bowl won’t be lit: no cannabis ads allowed (The Verge)

• Bill Introduced to Raise THC Limit in Hemp to One Percent (High Times)

• Cannabis Store Co-owned By Top Virginia Senator Sells Mislabeled Products With Illegal THC Content, Media Investigation Finds (Marijuana Moment)

• Study Shreds Cannabis ‘Amotivational Syndrome’ Theory (High Times)

• Flower still king of US marijuana market, though supremacy waning (Marijuana Business Daily)

• Oklahoma Becomes Marijuana Legalization Battleground Between Advocates, With Legal Challenges And A New Ballot Initiative (Marijuana Moment)

• New York Cracks Down on Illegal Cannabis Businesses (High Times)

• Missouri Supreme Court Unanimously Orders Medical Marijuana Applicant Disclosures (Marijuana Moment)

• Pennsylvania Senate committee holds first-ever hearing on legalizing recreational marijuana (WGAL)

• Police Seizure Of Marijuana Dispensary Cash Leads To Federal Litigation (Marijuana Moment)

• Cannabis platform Leafly closes merger with SPAC, goes public on Nasdaq (Marijuana Business Daily)

• The Eternal Pricing Struggle of UK Medical Cannabis Patients (TalkingDrugs)

• Weedmaps Ad Satirizes Plight Of Broccoli Emoji As Marijuana Stand-In On Social Media (Marijuana Moment)

• Young cannabis users at increased risk of repeat stroke (Medical News Today)

• Federally Owned Utility Company Walks Back Threat To Block Electricity For Marijuana Businesses (Marijuana Moment)

• Cali Vibes Rocks Long Beach, Allowing Cannabis (High Times)

• How does cannabis use affect brain health? Caution advised, more research needed, experts say (ScienceDaily)

LSD

• Microdose Psychedelics Presents a Molecular Masterclass: The LSD Conference (GlobeNewswire)

Magic Mushrooms

• Psilocybin microdosing does not reduce symptoms of depression or anxiety, according to placebo-controlled study (PsyPost)

• Lawmakers say no to bill legalizing psilocybin-assisted therapy in Maine (The Portland Press Herald)

• Oregon proposes only using one type of mushroom for new psilocybin system, and no pills (OPB)

• More States Follow Oregon’s Lead Toward Legal Psilocybin Therapy (Lucid News)

• Usona Identifies Controlled Crystal Engineering Process for Large-Scale Synthesis of Psilocybin Polymorphs (Business Wire)

• Maine CDC Director Opposes Bill to Legalize Therapeutic Psilocybin (Psychedelic Spotlight)

• The Many Types of Psychedelic Mushrooms (Truffle Report)

• Mazatec Shamanic Knowledge and Psilocybin Mushrooms (Chacruna)

MDMA

• Can MDMA Save a Marriage? (The New York Times)

DMT

• DMT Vape Pen Patent Illustrates a Big Problem in the Psychedelics Industry (Psychedelic Spotlight)

Ayahuasca

• Creating Awareness on Sexual Abuse in Ayahuasca Communities: A Review of Chacruna’s Guidelines (Chacruna)

5-MeO-DMT

• Scientists Create Cell-Based Psychedelic Toad Venom, a Potential 5-MeO-DMT “Bio-Factory” (Lucid News)

Mescaline

• Mescaline As Therapy Is Getting Attention, Despite Stigma (Green Market Report)

Iboga

• Osoyoos Indian Band eyes cutting-edge drug treatment centre (Vancouver Sun)

Novel Psychoactive Substances

• Cybin Announces Grant of U.S. Patent Covering its Proprietary Compound CYB004 (Deuterated DMT) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

Nitrous Oxide

• Another new weapon to beat Corona, first 'nasal spray' launched in India (News Track)

• Nitrous Oxide Safe For Dental Procedures In Children With Sickle Cell Disease: Study (Medical Dialogues)

Ketamine

• Ketamine effectively silences suicidal thoughts, especially in bipolar patients (Study Finds)

• Researching Ketamine for Social Anxiety Disorder (Truffle Report)

• Yale researcher receives grant to study effects of ketamine in individuals with epilepsy (Yale Daily News)

• Trip Tunes: A Conversation with Producer Jon Hopkins About Making Music for Ketamine (DoubleBlind)

• Ketamine Infusions in the Home May Facilitate Safe Treatment Access During the Pandemic (Pharmacy Times)

Miscellaneous

• Can microdosing psychedelics boost mental health? Here’s what the evidence suggests. (National Geographic)

• Utah House Overwhelmingly Approves Psychedelics Study Task Force Bill (Marijuana Moment)

• Maryland Senate Bill Would Provide ‘Cost-Free Access’ To Psychedelics For Military Veterans (Marijuana Moment)

• Psychedelics Offer New Route to Recovery from Eating Disorders (NEO.LIFE)

• Are Psychedelics the Future of Pain Relief? (VICE)

• Michigan Activists Submit Psychedelics Decriminalization Language (High Times)

• DEA Faces Backlash Over Proposed Scheduling Of Five Psychedelic Compounds (Marijuana Moment)

• Proposed Drug-Decrim Ballot Initiative All Set in Washington State (Filter)

• Can Psychedelics Make People More Drawn to Conspiracy Theories? (Sam Woolfe)

• Yes, Psychedelics Do Change Our Metaphysical Beliefs (DoubleBlind)

• Panel Discusses Coalition Building to Unlock Therapeutic Effects of Psychedelics (The Yale School)

• Legal Psychedelics: The U.S. Cities Where Psilocybin, LSD And Others Are Decriminalized (Healing Maps)

• Canada’s Reforms on Psychedelics Are Slowly Taking Shape (Bloomberg)

• Survey Shows 65% of Affected Americans Want Access to Psychedelic Treatments for Mental Health Conditions (Pharmacy Times)

• New Polling by Mind Medicine Australia Reveals Over 60% of Australians Support Increased Access to Psychedelic Medicines (Mind Medicine Australia)

• Big Pharma In Psychedelics: Inside Mindset Pharma’s Deal With Otsuka (Forbes)

• Using Real-World Evidence to Accelerate Psychedelic Drug Development (Truffle Report)

• Is city getting ‘high’ on hallucinating drugs? (The Hindu)

• Drug Euphoria Is a Good Thing, Actually (Filter)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Month in Psychedelics - December 2021

Happy Holidaze and Happy New Year! Due to an extra busy holiday season on my end, this month’s recap is a bit less detailed than normal and there isn’t a video version up on YouTube. However, I wanted to share December’s biggest highlights so you can get an idea of what happened in the world of psychedelics during the last month of 2021.

Followup

There’s some followup on last month’s story about fentanyl-tainted cannabis. Following the report that the first real case of it was found in Connecticut, a high school in Tennessee was thought to have fentanyl-laced vape pens circulating amongst its teenage students. However, perhaps we should be skeptical. After all, this may be a case of fentanyl panic rather than an actuality. The latest reports have shown that there wasn’t any fentanyl detected in cannabis in Vermont and Massachusetts. And the case in Connecticut is still under development.

Policy

Wins

There were two major drug policy wins this month. Port Townsend, Washington became the 13th city to decriminalize psychedelics and Malta became the first European country to legalize cannabis.

Losses

Not everything was successful though. An attempt to allow therapeutic use of psychedelics in Australia was rejected. The reasoning behind the denial was a lack of sufficient evidence, according to the country’s medical regulator.

Industry

A non-profit known as Freedom to Operate submitted a new legal filing that argues against Compass Pathways’ patent on its form of synthetic psilocybin based on the idea that it is not a novel invention. The results from this case will set a precedent for not just Compass Pathways but other psychedelic companies as well.

Research

Published Studies

Two studies were published this month worth mentioning. The first found that SSRIs can be used safely with psilocybin to treat depression and the second showed that people who use psychedelics were under less stress during Covid-19.

Future Studies

The FDA authorized a Phase 2 clinical trial to treat frontline clinicians dealing with Covid-related distress with psilocybin. The study will aim to assuage depression, anxiety, burnout and post-traumatic stress among doctors, nurses and healthcare professionals.

Research Centers

A new Center for Psychedelic Research and Therapy is launching at the University of Texas at Austin. The center will look at working with psychedelics in a clinical environment in the treatment of mental illness.

Miscellaneous

And last but not least, I’d like to encourage you one last time to take this year’s Global Drug Survey. Today’s the last day you can submit an entry and responses will help researchers better understand how and why people use drugs.

That’s all for this month’s update. Remember to always test and weigh your drugs and until next time—keep thinking wilder.

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

This Week in Psychedelics - 12.3.21

Cannabis

• Home of Dubai, the United Arab Emirates, Ends Jail Time for Travelers with THC (High Times)

• Mexico has a new marijuana legalization bill. Here’s what’s in it (Leafly)

• Reps. Dave Joyce and Alexandria Ocasio-Cortez Introduce Legislation To Expunge Marijuana Records (NORML)

• South Dakota's Governor Succeeds in Blocking Voter-Approved Marijuana Legalization (Reason)

• Fentanyl-laced vape pens among teens concern after Tennessee high school incident (WKYT)

• Record Number of Scientific Papers Published About Cannabis in 2021 (NORML)

• Death sentences upheld for two men convicted of cannabis trafficking (Singapore Law Watch)

• California rolls out plans to standardize cannabis testing statewide (Marijuana Business Daily)

• Jamaican Government Launches ‘Good Ganja Sense’ Campaign To Debunk Marijuana Myths (Marijuana Moment)

• Great News, Scientists Finally Figured Out Why Cannabis Smells 'Skunky' (ScienceAlert)

• Texas Activists Turn In Signatures To Put Marijuana Decriminalization On Austin’s 2022 Ballot (Marijuana Moment)

• Kentucky Lawmaker Pre-Files Marijuana Legalization Bills For 2022 Session (Marijuana Moment)

• Colorado University Announces Groundbreaking Study on Cannabis and Exercise (High Times)

• Massachusetts: Majority of Adults Say Marijuana Legalization Has Been “Positive” for the State (NORML)

LSD

• Blotter paper should be included while measuring weight of LSD, rules Bombay HC (India Today)

• How LSD changed The Beatles forever (Far Out Magazine)

Magic Mushrooms

• New Study Suggests SSRI Drugs Can Be Used Safely with Psilocybin to Treat Depression (Psychedelic Spotlight)

• Cybin Announces FDA Investigational New Drug and Institutional Review Board Approvals for a Co-Funded Phase 2 Clinical Trial to Treat Frontline Clinicians Experiencing COVID-Related Distress (Psilocybin Alpha)

• U of M Medical School launches new mechanistic study of psilocybin (University of Minnesota)

Ayahuasca

• Sexual Assault in the Amazon (The Cut)

Iboga

• Ibogaine and Cardiac Arrhythmia: The Heart of the Matter (Psychedelic Science Review)

Novel Psychoactive Substances

• MYND Life Sciences announces funding for Psilocybin research on Neuroinflammation (Psilocybin Alpha)

• Bright Minds Biosciences Provides Scientific Update on its Novel 5-HT2A Psychedelic Program for the Treatment of Mental Diseases (Psilocybin Alpha)

Nitrous Oxide

• ‘Everyone’s gagging for it’ – how Britain got high on nitrous oxide (The Guardian)

• Dozens of traffic accident deaths linked to laughing gas use (NL Times)

Ketamine

• Ketamine review: Chemical restraints may have been ‘disproportionately’ used on ‘communities of color’ (KDVR)

• As ketamine clinics emerge in Seattle to treat mental illness, so does debate about safety and regulations (The Seattle Times)

• PharmaTher Granted New Japanese Patent for KETABET™ (Ketamine Combination Formulation), Strengthening Global Patent Portfolio (Psilocybin Alpha)

Miscellaneous

• New York City Opens First Safe Consumption Sites For Illegal Drugs In The U.S. (Marijuana Moment)

• Florida Lawmaker Files Bill To Decriminalize All Currently Illicit Drugs (Marijuana Moment)

• Toronto May Be the Next City to Decriminalize Psychedelics and Other Drugs (Truffle Report)

• Study Shows People Who Use Psychedelics Were Under Less Stress During Covid-19 Lockdowns (Forbes)

• DEA Again Boosts 2022 Production Goals For Psychedelics Like Psilocybin, MDMA and DMT (Marijuana Moment)

• People ‘microdosing’ psychedelics to improve wellbeing during pandemic, drug survey finds (The Independent)

• Psychedelics may have long-term impact treating depression, mental illness - study (The Jerusalem Post)

• Psychedelic Telemedicine Has Arrived. What Could Possibly Go Wrong? (VICE)

• The Psychedelic Renaissance Is Ushering In a New Genre Of Electronic Music — And With It, New Revenue Streams (Billboard)

• Holiday Gift Guide 2021: Gifts For The Psychedelic Explorer (Forbes)

• Can ethics and sexual abuse allegations create backlash and impact the current psychedelic renaissance? (Chacruna)

• Will the psychedelic revolution bypass people of color? (The Lens)

• Celebrities: Are They Helping or Harming the Psychedelic Movement? (Psychedelic Spotlight)

• Origin Therapeutics Portfolio Company Tripsitter has Commenced Trading on the Canadian Securities Exchange (GlobeNewswire)

• Peter Thiel-backed psychedelic start-up increases stake in Compass Pathways (CNBC)

• Microdosing Protocols: Microdosing Every Day vs. Every Other Day (DoubleBlind)

• Editor’s Choice Award 2021-Best Study on Psychedelics and Neurochemistry (Psychedelic Science Review)

• Novel Psychedelic Treatment Approach Bypasses Hallucinogenic Effects to Allow Widespread Adoption (Pharmacy Times)

• Israeli start up makes pharmaceuticals out of psychedelic flora (i24 News)

• Getting Ahead of the Psychedelics Supply Crunch (Truffle Report)

• Numinus Develops Proprietary Psychedelic Tests with New Toxicity and Potency Scans (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.26.21

Cannabis

• The new German government plans to legalize cannabis. (The New York Times)

• Mexico Senate on Track to Endorse Recreational Cannabis by December (High Times)

• Uber Eats users in Ontario can now buy cannabis through the app (Engadget)

• New GOP weed approach: Feds must ‘get out of the way’ (Politico)

• South Dakota Supreme Court kills adult-use legalization (Leafly)

• Is Fentanyl-Tainted Marijuana 'Something Real' or 'Just an Urban Legend'? (Reason)

• A New Center at CSU Aims to Unlock the Secrets of CBD (5280)

• Indica and sativa labels are largely meaningless when it comes to cannabis complexities (The Conversation)

• St. Louis Lawmakers Unanimously Approve Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)

• Analysis: Marijuana Legalization Associated with Improved Clearance Rates for Violent Crimes (NORML)

• Illinois Judge Rules Weed Odor is Not Probable Cause For Searches (High Times)

• Ohio Marijuana Activists Almost Have Enough Signatures To Force Lawmakers To Consider Legalization (Marijuana Moment)

• New Mexico Issues First Adult-Use Cannabis Cultivation License (High Times)

• Taliban Contracts Australian Company To Grow Cannabis In Afghanistan (Marijuana Moment)

• Mississippi lawmakers unlikely to reach medical marijuana deal this year (Marijuana Business Daily)

• Dogs Are Being Exposed To Marijuana Through Human Poop And Pet Owners Should Beware, Study Finds (Marijuana Moment)

• Majority Of Texas Republicans Back Marijuana Legalization, Poll Finds (Marijuana Moment)

• Arizona Cannabis Social Equity Program Faces Legal Challenge (High Times)

• Canada’s first regulated cannabis suppositories target female consumers (Marijuana Business Daily)

• Montana: Officials Create New Drug Court to Focus Solely on Expunging Past Marijuana Convictions (NORML)

• Few Medical Cannabis Licenses in Portugal Have Been Awarded (High Times)

• Pennsylvania order targeting vaporized products upends cannabis market (Marijuana Business Daily)

• CNN’s Sixth WEED Documentary Features the Benefits of Medical Cannabis for Autism (High Times)

LSD

• New graphic novel depicts famed history of LSD research in Sask. (CBC)

Magic Mushrooms

• Magic mushroom study hints psilocybin repairs alcohol-induced brain damage (Inverse)

• COMPASS Pathways granted fifth US patent for crystalline psilocybin (Psilocybin Alpha)

• Metaphysics and mushrooms: Psychedelics can change how you think about the universe (Big Think)

• What Happens When Zen Monks Take Mushrooms? (Lucid News)

• HAVN Life Successfully Exports Psilocybin from its Jamaica Facility into Canada (Psilocybin Alpha)

MDMA

• Police Presence at Music Festivals Linked to "Panic Overdoses": Study (EDM)

DMT

• Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs (Psilocybin Alpha)

Ayahuasca

• Ayahuasca users report psychological benefits after taking placebo at a ritualistic ceremony (PsyPost)

• Are All Ayahuasca Retreats The Same? You Might Be Surprised (Healing Maps)

Peyote

• Mining and Poaching Threatens 15,000-Year-Old Peyote Tradition in Mexico (DoubleBlind)

San Pedro

• San Pedro: What is it Like to Experience Mescaline from San Pedro? (The Third Wave)

Novel Psychoactive Substances

• Mescaline-Like Psychedelic Alters Synaptic Plasticity (Technology Networks)

Ketamine

• Ketamine benefits neurocognition in depression with suicidal ideation (Healio)

• Wesana Health Clinics Surpass 4,000 Administered Ketamine Treatments (Psilocybin Alpha)

• PharmaTher Applies for FDA Orphan Drug Designation for Ketamine to Treat Rare Neurological Disorder Status Epilepticus (Psilocybin Alpha)

• Navigating the Patchwork of New York City Ketamine Clinics (Lucid News)

Miscellaneous

• New Zealand Permanently Legalizes Drug Checking, a Global First (Filter)

• U.S. Reports More Than 100,000 Overdose Deaths In One Year (High Times)

• New study finds 'microdosing' psychedelics can be effective in treating anxiety, depression (The Hill)

• Responding to the 2022 Global Drug Survey Will Help Other Drug Users (Filter)

• Colorado Springs Pushing to Decriminalize Psychedelics (Truffle Report)

• The Rise of Psychedelic Retreats (The New York Times)

• How to Cultivate a More Ethical, Inclusive Psychedelic Future (Lucid News)

• Why Are Some People More Sensitive to Psychedelics Than Others? (Sam Woolfe)

• Cybin Awards Grant for Psychedelic Treatment Clinic at Lenox Hill Hospital to Benefit Underserved Communities (Psilocybin Alpha)

• Academic Centers Start to Take Psychedelics Seriously (Medpage Today)

• Psychedelics and Mysticism: The Debate Continues (Psychedelic Science Review)

• Psychedelics, Cognition, and Sleep Disorders (Truffle Report)

• Is Psychedelic Research Funding Starting to Shift? (Medpage Today)

• Revive Therapeutics Files for ODD Designation for Bucillamine Treatment Targeting Rare Liver Disorders, COVID-19 (Truffle Report)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.5.21

Cannabis

• Voters In Seven Ohio Cities Approve Marijuana Decriminalization Ballot Measures, With Seven Others Defeated (Marijuana Moment)

• 3 Years Since the UK Legalised Medical Cannabis, and Only 3 NHS Prescriptions (Drug Science)

• New Congressional Report Provides Pathway for How the Biden Administration Can Deschedule Marijuana and Issue Blanket Pardons to Past Offenders (NORML)

• Pakistan Vows Cannabis Reform by End of Year (High Times)

• Strong Majority Of Americans Continues To Support Marijuana Legalization At Record High Level, New Gallup Poll Finds (Marijuana Moment)

• California legalized weed five years ago. Why is the illicit market still thriving? (The Guardian)

• Philadelphia Voters Approve Marijuana Referendum Calling For Statewide Legalization (Marijuana Moment)

• Virginia: Election Outcomes Likely to Influence Marijuana Legalization Launch (NORML)

• DEA Emboldens Delta-8 Hemp Businesses By Signaling That The Cannabinoid Is Federally Legal (Marijuana Moment)

• Marijuana Legalization Is Not Associated With Increased Mental Illness Or Suicide, New Study Finds, Despite Opposition Claims (Marijuana Moment)

• Mississippi Governor Stalls Medical Cannabis Bill (High Times)

• Legalizing Marijuana Reduces ‘Race-Based Arrests,’ American Medical Association Study Finds (Marijuana Moment)

• Cannabis growers eye drought-resistant strains to cope with water shortage (Marijuana Business Daily)

• Arkansas Activists File New Marijuana Legalization Initiative For 2022 Ballot (Marijuana Moment)

• Medical marijuana could ease anxiety, depressive symptoms, study shows (Marijuana Business Daily)

• Concentrates and vape products maintain dominance among heavy cannabis users (Marijuana Business Daily)

• Government-Grown Marijuana Is Genetically Closer To Hemp Than Cannabis Sold In Dispensaries, Another Study Finds (Marijuana Moment)

• Edibles and beverages are popular choices with new cannabis users (Marijuana Business Daily)

• Army Recruits Who’ve Used Marijuana ‘Perform No Worse’ Than Other Soldiers, Military-Funded Report Finds (Marijuana Moment)

Magic Mushrooms

• World-first trial of psilocybin therapy for anxiety disorders to begin in Australia (Happy Mag)

• Psilocybin-assisted psychotherapy might help to reduce attachment anxiety (PsyPost)

• Microdosing Moms: Psilocybin & Postpartum Depression Relief (Truffle Report)

• COMPASS Pathways to launch phase II trial of COMP360 psilocybin therapy for PTSD (Psilocybin Alpha)

• Psilocybe subaeruginosa: Australia’s Most Famous Magic Mushroom (DoubleBlind)

• A Case Study on Microdosing and Self-Care (The Third Wave)

• Psyched Wellness Announces That the Amanita Muscaria Mushroom Has Been Successfully Added to the Natural Health Products Ingredients Database (NHPID) of Canada (Psilocybin Alpha)

• The Missing Mushroom: Psychedelic Science and the Future of Psilocybin (Psychedelic Science Review)

• Braxia Scientific Graduates First Cohort of Medical Professionals from Psilocybin-Assisted Therapy Training Program; Ready to Start Health Canada Approved Psilocybin Clinical Trial (Psilocybin Alpha)

• Filament Health Announces FDA Authorization of Clinical Trial with First-Ever Direct Psilocin Administration and First-Ever Psychedelic Botanical Drug Candidates (Psilocybin Alpha)

DMT

• Algernon Pharmaceuticals Establishes 6 hours as Optimum Treatment Period for DMT in Neuron Study (Psilocybin Alpha)

• PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye Diseases (Psilocybin Alpha)

• Understanding A DMT Trip: From The Experience To Potential Side Effects (Healing Maps)

Mescaline

• Mescaline Revelations: Hume, Buddhism, and the Illusory Nature of the Self (Sam Woolfe)

Peyote

• The Compounds in Psychedelic Cacti (Psychedelic Science Review)

Iboga

• Ibogaine and Iboga: Traditional Use, Conservation, and Ethical Considerations (DoubleBlind)

Morning Glory Seeds

• Forgotten Psychedelics: LSA — Also Known as Ololiuqui (Psychedelic Spotlight)

Novel Psychoactive Substances

• atai Life Sciences Announces Supportive Interim Data from First 8-Patient Cohort of Phase 2a Trial for Novel Treatment of Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)

Ketamine

• Ketamine rapidly improves cognitive function, making those in suicidal crisis less likely to harm themselves (Medical Xpress)

• Kernel’s Brain-Imaging Helmet Approved For Clinical Trial On Patients Using Ketamine (Forbes)

• Klarisana's Newest Ketamine Study Shows IM Ketamine Therapy Comparable to IV Administration (PR Newswire)

• Study: Mixing CBD With Ketamine Might Be Great For Depression (Forbes)

• Ketamine Users Can Ensure Safety with DanceSafe’s New Testing Kit (Lucid News)

• Parents Are Very Open to Ketamine Therapy for Kids, Study Finds (Psychedelic Spotlight)

DXM

• ‘Robotripping’: Perth teens creating cough syrup cocktails as they chase a cheap high (The Age)

Miscellaneous

• Detroit Voters Decriminalize Psychedelics, Joining Ann Arbor (DoubleBlind)

• FDA Approves First Clinical Trial Using Naturally Sourced Psychedelics (Psychedelic Spotlight)

• The False Promise of Psychedelic Utopia (VICE)

• Classic Psychedelics Aren’t Addictive (Discover Magazine)

• Psychedelic Therapy Is Hyped, But It’s Not Risk-Free: How Therapy Abuse Can Retraumatize Clients (Forbes)

• New Orleans shoeshine man wins legal battle over $30,000 seized by DEA agents (NBC News)

• Washington D.C.’s 1st Year of Psychedelic Decrim (Truffle Report)

• Statewide Psychedelic Decriminalization Efforts Are Growing Across the Nation (Lucid News)

• PharmaTher Provides Research Update on Microneedle Patch Delivery Technologies for Psychedelics (Yahoo!)

• Wonderland: Miami Takes Shape as the Largest Psychedelic Medicine Business Event (High Times)

• Oregon’s Drug Decriminalization Has Raised Over $300 Million for Treatment and Services (Filter)

• ‘I’ve experienced states of consciousness beyond this life’: The people turning to psychedelics on their deathbeds (The Independent)

• How the Psychedelic Community Should Respond to Sexual Abuse (Lucid News)

• Psychedelic Research Beyond Depression & Trauma Part II (Truffle Report)

• Science Has Shown Me the Way Ahead with Psychedelics (Chacruna)

• We must address and deconstruct the stigma of psychedelics (The Michigan Daily)

• How Psychedelics Help with Parenting (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.